Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Nov 12 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-12-2024-13

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 12, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Ivabradine Tablets, 5 mg and 7.5 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases